We don’t need a new version of the DSM now. I am blogging today from Paris at the ECNP meeting, having attended the Royal Society of Medicine meeting outside of London last week to discuss the future of new drug development in psychiatry, paid by the taxpayers of the UK and charities, not Pharma. This meeting involved US colleagues Tom Insel, David Kupfer, and several academic experts and industry executives from the US and the UK and was covered by the BBC and a report of it aired on UK television. I will report the results of our discussions of new drug development in another blog in a few days. Having read the hailstorm of postings on our blog, I thought I would choose a topic on which many of us might agree. For now, many of us might actually agree on the value of the DSM 5 rewrite efforts – which is that it might be of little or no value…
… many of us are asking whether we need a DSM 5 at all. Those who do not believe there is any such thing as a mental illness like Scientologists and anti-psychiatrists, including people like Dr. Marcia Angell, in her recent NY Times Book Reviews, saying there is no such thing as depression in her reviews of various antipsychiatry books, will of course say no. The pharmascolds who think that Pharma is behind the invention of psychiatric disorders in order to market their drugs will also say no. However, you may be surprised how many of the mainstream scientific community would also agree that a revision of the DSM 5 may be unnecessary and certainly premature. I certainly think so.
The reality is that psychiatric disorders are not diseases at all and are not based on science or pathology, but on sociology, and politics of experts with opinions. Although those experts can no longer have any Pharma ties if they participate in the DSM revision process, they do have their pet theories to insert, and until there is a scientific basis of psychiatric conditions, based on genomics, environmental stresses, development, and brain circuits, the process will not be scientific and I am not confident that further advances can be made upon the sociology and politics of the previous DSM IV group.
until there is a scientific basis of psychiatric conditions, based on genomics, environmental stresses, development, and brain circuits, the process will not be scientific
until there is a scientific basis of the psychiatric conditions … the process will not be scientific
based on based on genomics, environmental stresses, development, and brain circuits
… having attended the Royal Society of Medicine meeting outside of London last week to discuss the future of new drug development in psychiatry
They’re near the end of their road, Dr. Stahl and his group. They’ve worn out the injunction to keep our eyes of the prize that sits just over the horizon. The metaphors of chemical imbalance, treatment resistant depression, evidence-based medicine, speculative neurobiology of this-and-that, augmentation, comorbidity, etc. have lost some of their former magic. So they live in a world of disillusionment with psychopharmacology and psychiatry in general, and an empty pipeline. Dr. Stahl and his cohorts are desperate to keep us where we’ve been – in the universe of science fiction where mental illness is to be treated solely with a steady stream of new pharmaceutical agents that appear [about the time the last group goes off-patent]. Ain’t going to happen. They’re out of drugs, and the marketeering hype that kept people trying to get more from the drugs than they ever had to offer is in the back-fire stage of its history. The days of Oz are over and the Wizard’s balloon headed back to Omaha.
So now we have to pick up the pieces. The real biological psychiatrists need to get back to the business of neuroscience that has to do with inching our understanding of mental illness forward rather than pretending that research means doing endless clinical trials. Clinical Psychiatrists have to rediscover the skills that justify including the treatment of mentally ill in a separate specialty of medicine – other than simply tweaking the drugs du jour and serving as detail men to the pharmaceutical industry. And the DSM definitely needs a revision – but not the one it’s getting. It needs a revision that puts it on an iterative path towards clinical usefulness. That process starts with a thorough reassessment of the Major Depressive Disorder diagnosis and its progeny. The category has essentially been unchanged for the last twenty-five years when it was created to eliminate depressive neurosis. It has remained hopelessly vague through the rise and fall of the SSRI antidepressants, justifying their widespread over-utilization. Both reasons are anachronistic. Maybe the time is finally right to make it into something that is useful to patients, clinicians, and researchers.
Just want to say how much I appreciate your blog. I discovered it a few months ago. I work as a psychiatrist in the Netherlands and recognize the things you write about all too well.
What also worries me in today’s psychiatry, besides the dominant role of psychocofarmacology you write about so well, is the growing bureaucracy: protocols, evidence based psychiatry, DSM based treatment guidelines, CBT as a panacee for almost everything etc. etc. A broad, humanistic view of psychiatric problems is almost absent. We are forced to diagnose en treat in one prescribed mode. And reality is so much more rich and complicated.
Dr. Marcia Angell doesn’t believe there is such a thing as depression?? Dr. Stahl does appear to have gone off the deep end.